• Follow the Money: New Diagnostics for Blood Infection, Dementia, Bone Disease

    Oct 28 | Diagnostics World News | Australian company nets cash for finger-prick blood infection diagnostic, AI-powered, “semi-autonomous” bone image diagnostics platform, NIH grants for non-Alzheimer’s dementias, and more. More
  • ‘Danger Molecule’ Associated With Inflammation, Obesity And Subclinical Cardiovascular Risk—And May Correlate With COVID-19

    Oct 26 | Diagnostics World News | It has been known for several years now that a “danger molecule” shows up in the blood when cells in the body are under stress or tissues are injured, inducing a potent inflammatory response—at least in rats. High Mobility Group Box-1 (HMGB1) is in fact one of the best characterized damage-associated molecular patterns. More
  • New Biomarkers, Antibody Tests, and Viral Detection Technologies: COVID-19 Updates

    Oct 23 | Diagnostics World News | IL-6 emerges as a promising biomarker, new antibody tests, and Monell Chemical Sciences Center reports loss of smell more prevalent than thought. Plus: new tests from Oxford Nanopore, Genalyte and optical technologies detect the virus. More
  • Next-Generation Pharmacovigilance With Natural Language Processing

    Oct 22 | Diagnostics World News | Surging use of telemedicine technology since the COVID-19 pandemic hit the U.S. earlier this year, but patients who complain of a pain in their leg can’t as easily show their doctor where and how it hurts via telemedicine. Natural language processing (NLP) thus has a potentially bigger role to play in automating diagnoses and the pharmacovigilance process, starting with interpreting data in free text fields and doing some of the cumbersome analytical work. More
  • Holographic Imaging Detects Virus, SARS-CoV-2 Specific IgG Antibodies Longest Lasting, Testing Wastewater for Coronavirus RNA: COVID-19 Updates

    Oct 16 | Diagnostics World News I Antibodies may provide immunity for several months, five cytokines identified that predict cytokine storm, Dublin-Boston score predicts severity of infection, pandemic related delays in CRC screening may cause significant increase in death rates from cancer, and Fluidigm to provide millions of saliva-based tests to US colleges and universities. Plus: Mount Sanai receives research funding to study impact of virus on lung cancer patients, SwabSeq has capability to test thousands of samples together but give individual results and more. More
  • Why the Precision Medicine Gap is the Biggest Threat to Healthcare and Why Predictive Diagnostics is the Key to Achieving True Precision Medicine

    Oct 14 | Diagnostics World News | The precision medicine gap, created by missing or outdated diagnostic technologies which have proved inadequate at providing a bridge between the numerous treatment options, and the subset of patients who will respond to them is one major obstacle holding back precision medicine. More
  • Mayo Building Home Hospital Model One Region, And Supply Chain, At A Time

    Oct 12 | Diagnostics World NewsWith a proper supply chain around a population of patients, and medical experts available to remotely oversee their care, a home could theoretically be transformed into a hospital on a moment’s notice. It’s a pioneering idea that the Mayo Clinic began actively exploring this summer with a pair of pilot programs in Jacksonville, Florida, and Eau Claire, Wisconsin. More
  • ‘Pooling’ Test Samples and Dipstick Technology, Persistent Symptoms During Pregnancy, At Home Finger Prick Test: COVID-19 Updates

    Oct 09 | Diagnostics World News | New ‘dipstick’ technology developed at the University of Queensland can quickly extract genetic material in as little as 30 seconds; CalTech researchers develop new sensor named SARS-CoV-2 RapidPlex; and dried blood spot samples are as accurate in detecting SARS-CoV-2 antibodies as venous blood samples study finds. Plus: NIH announces new RADx initiative contracts totaling $98.35 million; University of Minnesota AI evaluates chest X-rays to diagnose COVID-19; Boston launches TestBoston to track previous infection; and more. More
  • 3D Swabs, Saliva Sampling, Anosmia, Delirium: COVID-19 Updates

    Oct 02 | Diagnostics World News | Dialysis patients could help surveillance efforts, risk-raising genetic mutations, comparing return-to-work protocols, counting breaths, 3D nasal swabs and saliva sampling make the mark, cool tool for rapid antibody detection, resuming anticancer therapy, an Android app to analyze the SARS-CoV-2 genome, loss of smell, delirium in the elderly, AI+CT for diagnosing COVID-19. Plus, detecting fever from a distance, a COVID-19 biorepository expands to include convalescent plasma, more funding to improve testing for underserved populations, a smartwatch for asymptomatic individuals, and more of the latest news from around the U.S. and Europe. More
  • The Future of Wearables Could Be Electronic Tattoos

    Sep 30 | Diagnostics World News | New research offers a glimpse into the future of wearables, which may use everyday tools like pens, pencils, and paper to draw monitoring devices directly onto skin. More
View more articles

 
DXX-Industry-spotlight

Acrobiosystems

Antigens & Antibodies for SARS-CoV-2 Diagnostic Kit Development

ACROBiosystems team has worked tirelessly since the genomic sequence of SARS-CoV-2 was first published, developing a serial of high-quality antigen and antibody reagents to support the development of the diagnostic kits. The products include the high quality S trimer, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity tested on several platforms.

Click to learn more about ACRO’s hot matched antibody pairs and antigens.

DXX-Industry-spotlight

2020 Global Coronavirus Diagnostics Market


The report presents a detailed analysis of the Coronavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Coronavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: Hospitals, Commercial/Private Labs, Physician Offices and Public Health Labs.

Global Molecular Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts


The report takes the reader through a comprehensive review Molecular Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Molecular Diagnostics partnering deals. The report presents financial deal term values for Molecular Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyze and benchmark the financial value of deals. The middle section of the report explores the leading dealmakers in the Molecular Diagnostics partnering field; both the leading deal values and most active Molecular Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic deal making market.